Summary.-In view of the concern over the rising incidence of malignant melanoma in many parts of the world, and the suggestion that emigrants of Scottish and Irish descent have a higher incidence of melanoma in North America and Australia, a Scottish Melanoma Group has been formed to study epidemiological, pathological and therapeutic aspects of the tumour. In 1979, 260 histologically proven primary cutaneous malignant melanomas of the skin presented. This represents an incidence of 5 1/105 for Scotland as a whole. Studies over the next 5 years will determine whether the incidence of melanoma is rising in Scotland as rapidly as in other parts of the world.
RECENT EPIDIEMIOLOGICAL STULDIES on cutaneous malignant melanoma in various parts of the world have documented a rapid rise in the incidence of this malignancy in white-skinned races (Lee & Carter, 1970; Elwood et al., 1974; Waterhouse et al., 1976; Magnus, 1981; Teppo et al., 1978; Holman et al., 1980) . Three areas in which detailed sequential epidemiological studies have been performed are Queensland (Australia), Connecticut, and Arizona (U.S.). The figures from Queensland show a sharp increase in incidence from 16/105 in 1963-69 to 32-7/105 in 1977 (Little et al., 1980) , which is the highest recorded incidence of melanoma anywhere in the world. The Connecticut incidence rate of 1 1/105 in 1935 rose to 5-8/105 by 1974, with a more rapid increase apparent in males (Houghton et al., 1980) . The recent study from Arizona demonstrates a dramatic quadrupling of the incidence of melanoma over a 10-year period, from 6 5/105 in 1969 to 27.2/105 in 1978 (Schreiber et al., 1981) . This alarming rate of increase is the most rapid yet recorded, and applies exclusively to those of Northern European descent.
Studies from both Queensland and North America suggest that there is a, higher incidence of melanoma in that proportion of the population who are of "Celtic" descent. Large numbers of Scots and Irish emigrated to Queensland in the 19th century, and events such as the failure of the Irish potato harvest in 1845-46 and the highland clearances of the first half of the 19th century prompted a similar emigration to North America. Attempts have been made to determine the proportion of melanoma patients descended from Scots or Irish emigrants in these areas by compiling a list of surnames considered to be of Celtic origin. In both Queensland and Boston the incidence of melanoma in the population bearing suich names is significantly higher (Lane Brown et al., 1971; Lane Brown & Melia, 1973) .
There is therefore good circumstantial evidence to suggest that individuals from Scotland and Ireland who The reason for selecting these 4 objectives for initial study by the group was that precise details on all these aspects were not currently available for malignant melanoma in Scotland, though they had been established in other parts of the world as significant variables to be considered in the design of any collaborative trial on the treatment of melanoma. Knowledge of the incidence of the tumour and basic clinical information is essential in the statistical design of any trial involving such a rare tumour. Stratification according to pathological variables of prognostic significance has also been shown to be essential for the validity of any therapeutic trial on melanoma.
Scotland is considered to be a particularly useful site for epidemiological study for various other reasons. The population is relatively static, and tracer studies therefore present few problems. There is still a degree of genetic homogeneity which is no longer found in many parts of the world, especially in the United States, and as Scotland is a small country information can be readily obtained from all parts, since patients from the more remote areas, including the islands, are referred to the central belt and are easily registered and followed up.
The Breslow (1977) . This involves the use of an ocular micrometer to measure (in mm) the thickness of the tumour from the overlying granular layer in the epidermis to the deepest invasive tumour cell.
DISCUSSION
The details recorded in the first year's work of the Scottish Melanoma Group indicate that at the present time 260 patients with primary, cutaneous melanoma present annually. The incidence of 5-1/105 p.a. is difficult to compare with figures for other cancer registries in the U.K., as those published for Oxford and East Anglia relate to the periods 1962-1970 and 1961-1971 (Bakos & MacMillan, 1973; Sverdlow, 1979 (McCarthy et al., 1980; Little et al., 1980; Magnus, 1981) . In each of these 3 studies a rapidly increasing incidence of malignant melanoma in the area under study is reported, with a doubling in incidence rate over each 7-9 years. If the genotype of the Australian and Scottish populations are indeed similar, it would appear that environmental factors in Queensland increase the current incidence of malignant melanoma [5] [6] fold. It will be seen from Table II that the ratio of affected females to males shows an excess of females in all decades. These ratios are in broad agreement with the figures recently published for England and Wales for the earlier period 1968-71, and add circumstantial evidence to the suggestion that in relatively low-incidence areas a hormonally dependent or related aetiological factor results in a higher incidence in premenopausal females than in males of the same age range (Lee & Storer, 1980) . The ratio of 2 females to one male is similar to that reported in other countries with a relatively low incidence of melanoma, whereas in countries such as Australia with a high incidence the two sexes tend to be affected equally (Lee & Storer, 1980) . Comparison with figures collected in Norway for 1977 shows an incidence in males and females which is equal at 10.9/105 in 1977 and an increase of -7% p.a. is reported (Magnus, 1981) .
This contrasts strongly with the striking female male ratio in Scotland of 2.17%. It will be of interest to see whether or not this sex difference becomes less marked if the Scottish figures rise to levels approaching those for Norway. Table III illustrates the high preponderance of lesions on the lower leg in females. Once again this is a common finding in other large published series.
The work of Clark, Breslow, Balch and their associates in the past decade has greatly extended the volume of useful information, often of considerable prognostic significance, which can be obtained from light-microscopic examination of appropriate blocks of paraffin-embedded tissue (Clark et al., 1969; Breslow, 1977; Breslow & Macht, 1978; Balch et al., 1978 Balch et al., , 1979 Balch et al., , 1980 . Clark has suggested that there are several different histogenetic precursors or lateral growth phases of the pre-invasive epidermal component of cutaneous malignant melanoma. The 4 main histogenetic varieties of melanoma currently recognised are lentigo maligna, superficial spreading, nodular and acral lentiginous. Of these, the commonest in large reported series is the superficial spreading variety, and it will be seen that the Scottish figures (48%) also show this trend (Table IV) . It is of interest that a higher proportion of lentigo maligna melanomas were diagnosed in Queensland in 1977 than in 1966 (Little et al., 1980 in females, whereas the SMG figure for 1979 is 130%. There is strong circumstantial evidence that cumulative total lifetime exposure to solar radiation plays a significant role in the aetiology of lentigo maligna melanoma (McGovern et al., 1980) whereas the available evidence for superficial spreading and nodular melanoma suggests that intermittent sun exposure and burning may be a more important aetiological feature (Lancet, 1981) . Nodular malignant melanoma is a lesion with no residual evidence of any in situ or lateral growth phase in the 6 epidermis, and only a vertically invasive component. Our current understanding of the biological processes underlying malignant transformation would suggest that this lesion is not ab initio an aggressive vertically invasive lesion, but rather that the rapid rate of tumour expansion in this situation has obliterated all evidence of an in situ or pre-invasive phase. This group, which generally forms the majority of deeply invasive poor-prognosis tumours, currently comprises 25% of the Scottish series.
It will be seen from Table V that in 1979 63 patients (24%) had tumours > 4 mm thick. It is now well established that there is an inverse linear relationship between tumour thickness and survival and figures from other studies suggest that the 5-year survival rate for patients with lesions of this thickness is only 38%, even after adequate and extensive surgical excision (Pondes et al., 1981) . This therefore is a group in which studies of appropriate adjuvant therapy are urgently needed.
This would appear to be the first occasion on which a population-based group has had accurate histogenetic typing and measurement of tumour thickness carried out at the time of diagnosis. This is significant, as in retrospective studies lack of provision of suitable blocks may reduce the accuracy of these assessments.
If present trends continue the SMG will have accumulated extensive clinical and pathological information on 2500 patients with malignant melanoma by 1990. Much basic information on the incidence, morbidity and modes of treatment of this tumour will have been collected, and careful analysis of this data should allow valid conclusions to be reached about changes in its incidence, management, and behaviour in the Scottsh population.
All population figures in this paper are taken from the Annual Return of the Registrar General for Scotland, December 1979.
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